Paper
0
External validation of the PE-SARD bleeding score for early major bleeding in patients with acute pulmonary embolism: From the COMMAND VTE Registry-2
Authors
Yuji Nishimoto,Yugo Yamashita
Takeshi Morimoto,Ryuki Chatani,Kazuhisa Kaneda,Nobutaka Ikeda,Yohei Kobayashi,Yoshiaki Tsuyuki,Moriaki Inoko,Toru Takase,Shuhei Tsuji,Kazunori Otsui,Jiro Sakamoto,Yoshito Ogihara,Shunsuke Usami,Po‐Min Chen,Kiyonori Togi,Norimichi Koitabashi,Seiichi Hiramori,Kosuke Doi,Kensuke Takabayashi,Hidekatsu Nakai,Daisuke Sueta,Wataru Shioyama,Yusuke Yoshikawa,Yukihito Sato,Tetsuya Watanabe,Takahisa Yamada,Masatake Fukunami
+27 authors
,Sosuke TsujiPublished
Jun 1, 2024
Show more
Save
Tip0
TipSave
Abstract
There is no established risk score for anticoagulant-related bleeding during the acute phase in patients with pulmonary embolism (PE). The Syncope, Anemia, Renal Dysfunction (PE-SARD) bleeding score was developed to predict early major bleeding, but has not yet been fully externally validated.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.